Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

A joint model for the dependence between clustered times to tumour progression and deaths: A meta-analysis of chemotherapy in head and neck cancer.

Rondeau V, Pignon JP, Michiels S; MACH-NC collaborative Group.

Stat Methods Med Res. 2015 Dec;24(6):711-29. doi: 10.1177/0962280211425578. Epub 2011 Oct 23.

PMID:
22025414
2.

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients.

Pignon JP, le Maître A, Maillard E, Bourhis J; MACH-NC Collaborative Group.

Radiother Oncol. 2009 Jul;92(1):4-14. doi: 10.1016/j.radonc.2009.04.014. Epub 2009 May 14.

PMID:
19446902
3.

Long-term results of a prospective multicenter phase II study to preserve the larynx function using concomitant boost radiochemotherapy with Carboplatin.

Rudat V, Eckel H, Volling P, Schröder M, Staar S, Wallner F, Wannenmacher M, Dietz A.

Radiother Oncol. 2008 Oct;89(1):33-7. doi: 10.1016/j.radonc.2008.06.005. Epub 2008 Jul 11.

PMID:
18621428
4.

Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: updated results of a randomized multicentric trial in advanced head-and-neck cancer.

Semrau R, Mueller RP, Stuetzer H, Staar S, Schroeder U, Guntinas-Lichius O, Kocher M, Eich HT, Dietz A, Flentje M, Rudat V, Volling P, Schroeder M, Eckel HE.

Int J Radiat Oncol Biol Phys. 2006 Apr 1;64(5):1308-16. Epub 2006 Feb 7.

PMID:
16464538
5.

[Organ preservation in advanced laryngeal and hypopharyngeal carcinoma by primary radiochemotherapy. Results of a multicenter phase II study].

Dietz A, Nollert J, Eckel H, Volling P, Schröder M, Staar S, Conradt C, Helmke B, Dollner R, Müller RP, Wannenmacher M, Weidauer H, Rudat V.

HNO. 2002 Feb;50(2):146-54. German.

PMID:
12080625
6.

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer.

Staar S, Rudat V, Stuetzer H, Dietz A, Volling P, Schroeder M, Flentje M, Eckel HE, Mueller RP.

Int J Radiat Oncol Biol Phys. 2001 Aug 1;50(5):1161-71. Erratum in: Int J Radiat Oncol Biol Phys 2001 Oct 1;51(2):569.

PMID:
11483325
7.

[Incidence of salivary fistulas in relation to timing of oral nutrition after laryngectomy].

Volling P, Singelmann H, Ebeling O.

HNO. 2001 Apr;49(4):276-82. German.

PMID:
11382108
8.

Surgical treatment for hypopharynx carcinoma: feasibility, mortality, and results.

Eckel HE, Staar S, Volling P, Sittel C, Damm M, Jungehuelsing M.

Otolaryngol Head Neck Surg. 2001 May;124(5):561-9.

PMID:
11337663
9.

[Clinical manifestation of Ewing's sarcoma as a retrotonsillar pharyngeal tumor].

Singelmann H, Bielefeld K, Ebeling O, Volling P.

Laryngorhinootologie. 2001 Mar;80(3):161-5. German.

PMID:
11320880
10.

[Quality assurance in ENT tumor surgery].

Eckel HE, Streppel M, Schmalenbach K, Volling P, Schrappe M, Dietz A, Bootz F.

HNO. 2000 Dec;48(12):902-10. German.

PMID:
11196091
11.

[Prognostic value of hemoglobin level for primary radiochemotherapy of head-neck carcinomas].

Dietz A, Rudat V, Conradt C, Vanselow B, Wollensack P, Staar S, Eckel H, Volling P, Schröder M, Wannenmacher M, Müller RP, Weidauer H.

HNO. 2000 Sep;48(9):655-64. German.

PMID:
11056853
12.

[Prognostic relevance of proliferation marker Ki-67 (MIB 1), PCNA and p53 in combined surgically and radiologically treated cancers of the oropharynx and mouth cavity].

Sittel C, Ruiz S, Kvasnicka HM, Volling P, Jungehülsing M, Eckel HE.

Laryngorhinootologie. 2000 Feb;79(2):86-92. German.

PMID:
10738715
13.

Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.

Sittel C, Ruiz S, Volling P, Kvasnicka HM, Jungehülsing M, Eckel HE.

Oral Oncol. 1999 Nov;35(6):583-9.

PMID:
10705094
14.

[Adverse effects of cytostatic chemotherapy in patients with head and neck carcinomas. Prevention and therapy].

Volling P, Ebeling O.

HNO. 1999 Nov;47(11):999-1015. Review. German. No abstract available.

PMID:
10602794
15.

[Results of a prospective randomized trial with induction chemotherapy for cancer of the oral cavity and tonsils].

Volling P, Schröder M, Eckel H, Ebeling O, Stennert E.

HNO. 1999 Oct;47(10):899-906. German.

PMID:
10550374
16.
17.
18.

Transoral laser resection with staged discontinuous neck dissection for oral cavity and oropharynx squamous cell carcinoma.

Eckel HE, Volling P, Pototschnig C, Zorowka P, Thumfart W.

Laryngoscope. 1995 Jan;105(1):53-60. Review.

PMID:
7837914
19.

Transoral laser surgery for oral carcinoma.

Eckel HE, Volling P, Ebeling O, Schneider I, Thumfart WF.

Adv Otorhinolaryngol. 1995;49:185-90. No abstract available.

PMID:
7653361
20.

[Cisplatin/5-FU versus carboplatin/5-FU. 5 year follow-up].

Ebeling O, Eckel HE, Volling P, Heitmann K, Vössing M.

HNO. 1994 Oct;42(10):629-35. German.

PMID:
8002371

Supplemental Content

Loading ...
Support Center